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Background: Prior evidence suggests that longer duration of residence in the southeastern United States is
associated with higher prevalence of diabetes and hypertension. We postulated that a similar association would
exist for chronic kidney disease (CKD).
Methods: In a national population-based cohort study that enrolled 30,239 men and women ≥ 45 years old (42%
black/58% white; 56% residing in the Southeast) between 2003 and 2007, lifetime southeastern residence duration
was calculated and categorized [none (0%), less than half (>0-< 50%), half or more (≥50-< 100%), and all (100%)].
Prevalent albuminuria (single spot urinary albumin:creatinine ratio of ≥30 mg/g) and reduced kidney function
(estimated glomerular filtration rate <60 ml/min/1.73 m2) were defined at enrollment. Incident end-stage renal
disease (ESRD) during follow-up was identified through linkage to United States Renal Data System.
Results: White and black participants most often reported living their entire lives outside (35.7% and 27.0%,
respectively) or inside (27.9% and 33.8%, respectively) the southeastern United States. The prevalence of neither
albuminuria nor reduced kidney function was statistically significantly associated with southeastern residence
duration, in either race. ESRD incidence was not statistically significantly associated with all vs. none southeastern
residence duration (HR = 0.50, 95% CI, 0.22-1.14) among whites, whereas blacks with all vs. none exposure showed
increased risk of ESRD (HR = 1.63, 95% CI, 1.02-2.63; PraceXduration = 0.011).
Conclusions: These data suggest that blacks but not whites who lived in the Southeast their entire lives were at
increased risk of ESRD, but we found no clear geographic pattern for earlier-stage CKD.
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Chronic kidney disease (CKD), defined by albuminuria
or reduced estimated glomerular filtration rate (eGFR),
is common among adults in the United States (esti-
mated prevalence >10%) [1], and, in 2009, more than
600,000 individuals with CKD were treated for
end-stage renal disease (ESRD) [2], requiring dialysis
or kidney transplantation to sustain life. Substantial
geographic variation exists in the age-, race- and
sex-adjusted incidence of ESRD in the United States,
and many of the southeastern states (which overlay the
so-called “stroke belt” [3]) have higher incidence than
many other U.S. regions [2]. Further, both diabetes [4]
and hypertension [5], which are strong risk factors for
CKD, have been shown to be more prevalent in the
southeastern United States, compared to the rest of
the country. This raises the possibility that regional
factors that are associated with increased risk of devel-
oping diabetes and hypertension during one’s lifetime,
as well as the diseases themselves, might contribute to
a higher risk of CKD and ESRD among residents of
this region. Factors that could vary by region and also
affect these risks include behavioral (e.g., diet and
physical activity), environmental (e.g., water quality and
food availability), and possibly unknown population-
level genetic factors.
Despite increasing interest in the geographic aspects
of CKD epidemiology [6], there remains little known
about the associations of the duration of residence in the
southeastern United States with prevalence of CKD and
incidence of ESRD. Additionally, since diabetes and
hypertension have also been shown to be more prevalent
among blacks compared to whites [7], the degree to
which race may affect such associations is of interest.
Thus, we hypothesized that, in a national population-
based cohort of community-dwelling individuals aged
≥45 years [the REasons for Geographic and Racial
Differences in Stroke (REGARDS) cohort], longer dur-
ation of residence in the Southeast would be associated
with higher prevalence of albuminuria and reduced kid-




Participants with complete residence information had a
mean age of 65 years; overall, approximately 56% were fe-
male, 40% were black, and 35% were college graduates. In
general, females, those without a college education, cur-
rently living in a non-urban location, with diabetes, and
with hypertension had higher southeastern residence dur-
ation. Participant characteristics by southeastern residence
duration and race are shown in Table 1. Black participants
were more likely to be younger and female and to haveless education, lower income, lower residential mobility,
urban residence, higher BMI, diabetes and hypertension,
compared to whites; they were less likely to use NSAIDs
regularly. On average, blacks had higher albumin:creatin-
ine ratios and eGFRs than whites.
The majority of participants had spent their entire life-
time either outside (32.3%) or inside (30.3%) the Southeast.
The median southeastern residence duration was 46.8%
(47.8% for whites and 45.8% for blacks; 33.9% for males
and 59.4% for females). Figure 1 shows that the majority of
participants spent 100% of their lives (“all”) or 0% of their
lives (“none”) in the Southeast. White participants more
often, and black participants less often, reported no vs. en-
tire life in the Southeast (whites, 35.7% vs. 27.9%; blacks,
27.0% vs. 33.8%).
Prevalence of albuminuria by southeastern residence
duration
Albuminuria was more prevalent in both whites and
blacks who either spent none or all of their life in the
Southeast, relative to those who spent part but not all of
their life in the region (Table 2). Additionally, the crude
prevalence of albuminuria was higher in blacks than
whites in every southeastern residence duration category.
The PORs, relative to the “none” (0%) southeastern resi-
dence duration category, show somewhat increased preva-
lence for the “all” (100%) southeastern residence duration
category. For example, with adjustment for age and sex
and compared to no southeastern residence, whites who
spent all of their lives in the Southeast had a POR of 1.16
(95% CI, 1.02-1.31). However, this association became
non-significant with further adjustment for clinical factors
and SES (Table 3). In the black population, we found no
pattern of higher prevalence with longer duration of
southeastern residence. Rather, blacks with lifetime
southeastern residence duration less than half (>0% and
<50%) and half or more (≥50% and <100%) had age- and
sex-adjusted PORs of 0.87 (95% CI, 0.76-1.00) and
0.80 (95% CI, 0.68-0.95), respectively, relative to blacks
with no residence in the region, and these associations
persisted with further adjustment. The statistical signifi-
cance of the interaction by race of the association between
southeastern exposure and albuminuria prevalence was
attenuated with adjustment for SES.
In sensitivity analyses, income-stratified analyses
(Table 4) showed that the lack of association of albumin-
uria with southeastern residence duration was similarly
present in high (>$35,000)- and low (<$35,000)-income
groups. Neither the three-way interaction term of in-
come, race, and southeastern residence duration nor
two-way interactions of race with southeastern residence
duration in stratified models were statistically significant.
When residence duration was categorized in evenly
spaced intervals of length 20% (excluding the 0%




Total None <Half ≥Half All Total None <Half ≥Half All
N (%) 16,381 5,851 (35.7) 2,447 (14.9) 3,509 (21.4) 4,574 (27.5) 10,689 2,885 (27.0) 2,566 (24.0) 1,626 (15.2) 3,612 (33.8)
Demographic
Mean age in years (SD) 65.5 (9.5) 65.9 (9.7) 65.5 (9.1) 65.4 (9.1) 65.1 (9.5) 64.1 (9.2) 64.4 (9.4) 66.1 (8.8) 62.5 (8.7) 63.0 (9.2)
% female 50.5 47.4 44.1 52.0 56.6 63.9 63.3 59.4 61.6 68.7
Socioeconomic status
% college graduate 41.4 45.8 50.7 42.7 29.6 26.2 28.8 24.4 30.1 23.7
Annual income
% < $35,000 34.4 32.3 29.3 35.0 39.6 52.8 49.4 51.7 51.8 57.0
%≥ $35,000 53.4 55.6 59.8 53.7 47.0 34.7 38.9 36.6 37.6 28.8
% refused 12.1 12.1 11.0 11.3 13.3 12.4 11.8 11.8 10.7 14.2
Residence
% 5+ lifetime movesa 50.2 46.9 74.9 69.7 26.2 17.6 14.7 21.4 37.6 8.2
% ≥20 years at current residence 53.8 54.0 33.7 61.1 58.6 64.9 62.9 68.7 70.3 61.5
% urban 69.3 81.8 67.1 65.9 56.4 90.4 99.0 96.0 82.4 83.1
Access
% insured 95.8 96.5 95.9 95.7 94.8 90.3 92.2 93.2 89.1 87.3
% with regular medical care 84.3 84.4 83.1 84.4 84.6 81.7 80.9 81.4 82.5 82.3
Clinical
% current smoker 12.3 10.9 11.8 13.8 13.2 17.2 18.3 16.9 19.4 15.6
% obese (BMI >30 kg/m2) 30.9 30.4 30.5 29.2 33.2 48.7 46.9 46.3 47.2 52.4
% using NSAIDS 16.3 15.6 15.2 17.8 16.7 11.9 11.7 11.2 12.2 12.3
% using ACEI/ARBs 31.6 29.0 30.8 32.8 34.4 42.0 39.4 40.6 41.1 45.3
% with diabetes 15.3 13.2 14.3 16.2 18.0 30.3 28.1 27.4 29.9 34.3
% with hypertension 50.3 47.3 49.7 51.3 53.7 71.7 69.0 72.3 69.6 74.3
% family history of ESRD 4.7 4.3 4.1 4.8 5.6 10.7 8.8 9.5 11.2 12.7
Mean ACRb (SD) 9.30 (2.94) 9.21 (2.92) 8.76 (2.77) 9.39 (3.06) 9.68 (3.06) 11.94 (4.06) 12.18 (4.06) 11.70 (4.06) 10.59 (3.82) 12.55 (4.18)
Mean eGFR (SD) 82.6 (17.1) 82.1 (17.0) 83.2 (16.4) 82.8 (17.1) 82.8 (17.5) 88.7 (23.3) 88.9 (23.5) 86.5 (22.8) 90.4 (21.8) 89.4 (24.1)
Southeastern residence duration: total, all participants; none, 0% of life spent in Southeast; <half, >0%-50% of life spent in Southeast; ≥half, ≥50%-< 100% of life spent in Southeast; all, 100% of life spent in Southeast.
The Southeast included North Carolina, South Carolina, Georgia, Alabama, Mississippi, Tennessee, Arkansas, and Louisiana; other included the 40 other contiguous U.S. states (excluding Alaska and Hawaii).
BMI, body mass index (kg/m2); ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; NSAID, non-steroidal anti-inflammatory drug; ACR, albumin:creatinine ratio (mg/g); eGFR; estimated
glomerular filtration rate (ml/min/1.73 m2). Diabetes and hypertension were defined by self-reported diagnoses; self-reported use of insulin or oral hypoglycemic and anti-hypertensive medications; or measured fasting
blood glucose ≥126 mg/dl or random glucose ≥200 mg/dl and blood pressure >140/>90 mmHg, respectively.
Missing data (whites and blacks): education, n = 19; insurance; n = 21; routine source of medical care, n = 970; urbanization of current residence, n = 2,612; smoking, n = 105; BMI, n = 187; regular use of NSAIDs, n = 101;
diabetes, n = 969; hypertension, n = 65; albuminuria, n = 1273; eGFR, n = 1105. For those variables with >10% of data missing, ‘unknown’ was included as a category in the table.
P < 0.001 in whites and blacks across southeastern exposure categories, by chi-square (categorical) and ANOVA (continuous) tests, for all characteristics shown, except routine site for medical care (P > 0.05 for whites
and blacks).
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southeastern residence duration of 80-99% was associ-
ated with a fully adjusted POR of 0.71 (95% CI, 0.58-
0.88), relative to 0% among blacks, but no other resi-
dence duration category was associated with prevalent
albuminuria in blacks; no associations were seen among
whites. Additionally, whether participants had spent the
first 18 years of life in the Southeast (vs. not) was not as-
sociated with albuminuria: fully adjusted POR = 1.02
(95% CI, 0.94-1.13) and 0.94 (95% CI, 0.84-1.05), for
whites and blacks, respectively. Finally, the age × dur-
ation term was not statistically significant for whites
(P = 0.99) or blacks (P = 0.42) in fully adjusted models.Prevalence of reduced kidney function by southeastern
residence duration
Crude prevalence of reduced kidney function was similar
across all southeastern residence duration categories, re-
gardless of race (Table 2). For most categories, blacks had
higher prevalence of reduced kidney function than whites
(Table 2). For example, in the 100% southeastern resi-
dence duration category, prevalence of reduced kidney
function was 12.2% and 11.3% in blacks and whites.
Table 3 shows that duration of southeastern residence was
not associated with odds of reduced kidney function
among whites. Similarly, among blacks, we found no
dose-response pattern. Additionally, tests for interactions
of race with southeastern residence duration were not sta-
tistically significant.
Sensitivity analyses showed a similar lack of associ-
ation of southeastern residence with reduced kidneyFigure 1 Crude distribution of lifetime southeastern residence duratio
Southeastern U.S. states included: North Carolina, South Carolina, Georgia, A
included the 40 other contiguous U.S. states (excluding Alaska and Hawaii)function was seen when the stricter cutoff of eGFR < 45
ml/min/1.73 m2 was used (data not shown). Income-
stratified analyses (Table 4) showed that the associations
of reduced kidney function with southeastern residence
duration were similarly null in high- and low-income
groups, with the exception of the more than half vs.
none southeastern residence category in blacks of high
income. With evenly spaced cutoffs (intervals of 20%,
excluding the 0% and 100% categories), results were
similarly null, compared to those reported in the main
analyses (data not shown). Also, whether participants
had spent the first 18 years of life in the Southeast
(vs. not) was not associated with reduced kidney func-
tion: POR = 1.00 (95% CI, 0.89-1.12) and 0.96 (95% CI,
0.84-1.09), for whites and blacks, respectively. Finally,
the age × duration term was not statistically significant
for whites (P = 0.90) or blacks (P = 0.86).Incidence of ESRD by southeastern residence duration
Among whites, the crude incidence of ESRD was lowest
in the all lifetime southeastern residence duration category
and highest in the none category (536.1 and 1149.5 per
million patient-years, respectively; Table 2). However, this
difference was not statistically significant. In contrast,
among blacks, those who had spent their entire life in the
Southeast had the highest crude incidence of ESRD and
those who had never lived in the region had the lowest in-
cidence rate (4262.9 and 2829.2 per million patient-years,
respectively; Table 2). Most categories of southeastern
residence were not statistically significantly associated
with ESRD incidence (Table 3). Blacks who lived theirn, by race. Bars, crude percentage of participants in each category.
labama, Mississippi, Tennessee, Arkansas, and Louisiana; other
.
Plantinga et al. International Journal of Health Geographics 2013, 12:17 Page 5 of 12
http://www.ij-healthgeographics.com/content/12/1/17entire lives in the Southeast had increased risk of ESRD
relative to those who never lived in the Southeast (fully
adjusted POR vs. none, 1.63; 95% CI, 1.02-2.61). The stat-
istical interaction of race with southeastern residence dur-
ation in this fully adjusted model was statistically
significant (Pinteraction = 0.011).
In sensitivity analyses, income-stratified analyses
(Table 4) showed that the associations of ESRD with
southeastern residence duration were similarly non-
statistically significant in high- and low-income groups.
Associations were similar in the two income groups
among whites. Among blacks, HRs were suggestive of a
harmful effect of greater southeastern residence duration
in those with low income but a protective effect in those
with high income. The three-way interaction term of in-
come, race, and southeastern residence duration was sta-
tistically significant (P = 0.028). When residence duration
was categorized in evenly spaced intervals of length 20%
(excluding the 0% and 100% categories), results were
similar: only the 100% residence category was associated
with greater risk of ESRD among blacks, with a HR of
1.63 (95% CI, 1.02-2.61). The first 18 years spent in the
Southeast (vs. not) was protective in whites (HR = 0.66,
95% CI, 0.35-1.26) and harmful in blacks (HR = 1.24,
95% CI, 0.86-1.79), but neither association was statisti-
cally significant. Finally, the age × duration term was sta-
tistically significant among whites (P = 0.02) but not
blacks (P = 0.37). The significance of the interaction term
appeared to be due to a lack of events in the <50% dur-
ation category among younger whites and not due to
any overall difference between older and younger whitesTable 2 Crude prevalence of albuminuria and reduced kidney




Crude prevalence of albuminuria
No. of events 670 245 399 5
No. of individuals 5619 2348 3377 4
Prevalence (%) 11.9 10.4 11.8 1
Crude prevalence of reduced kidney function
No. of events 619 218 347 4
No. of individuals 5640 2364 3414 4
Prevalence (%) 11.0 9.2 10.2 1
Crude incidence of end-stage renal disease
No. of events 23 5 12
No. of individuals 5839 2447 3504 4
Incidence (per million person-years) 1149.5 589.8 1007.6 5
Southeastern U.S. states included: North Carolina, South Carolina, Georgia, Alabama
contiguous U.S. states (excluding Alaska and Hawaii).
aBy χ2 (albuminuria, reduced kidney function) and log-rank (end-stage renal disease
bBy Cochran-Armitage (albuminuria, reduced kidney function) and log-rank (end-stain the association of duration with risk of incident ESRD,
as the HRs for 100% vs. 0% categories were quite similar
among whites <65 and ≥65 years old: 0.50 (95% CI,
0.14,1.81) and 0.44 (95% CI, 0.14,1.35), respectively.
Discussion
In this national cohort, we found that higher prevalence
of albuminuria and reduced kidney function was not as-
sociated with longer duration of Southeastern residence
among either whites or blacks. Results were suggestive
of an association between lifetime southeastern resi-
dence duration and increased risk of ESRD, but only
among blacks. The interaction between race and south-
eastern residence duration for ESRD suggests effect
modification by race, such that lifetime exposure to the
Southeast appeared to be harmful for blacks but not
whites. This effect modification persisted among those
with lower but not higher income.
Diabetes and hypertension account for the majority of
ESRD in the United States [2]. Studies of diabetes have
shown that it is more common among those living in the
Southeast, often referred to as the “stroke belt” [3]. In fact,
a “diabetes belt” [4] that overlays the stroke belt has re-
cently been proposed, based upon national survey preva-
lence estimates. Hypertension has also been associated
with the duration of residence in the stroke belt in a dose-
response manner (i.e., higher lifetime exposure to the
stroke belt was associated with higher prevalence of
hypertension) [5]. In addition, racial disparities in both
diabetes and hypertension persist, with blacks having
higher prevalence of both conditions compared to whitesfunction and crude incidence of end-stage renal disease,
time southeastern residence duration
Black
All P None <Half ≥Half All P
60 0.044a 534 443 243 671 0.037a
380 0.149b 2728 2431 1541 3373 0.876b
2.8 19.6 18.2 15.8 19.9
97 0.042a 316 301 152 417 0.067a
418 0.670b 2714 2443 1552 3420 0.895b
1.3 11.6 12.3 9.8 12.2
8 0.278a 30 29 15 48 0.076a
564 0.192b 2866 2537 1618 3575 0.009b
36.1 2829.2 3152.7 2891.9 4262.9
, Mississippi, Tennessee, Arkansas, and Louisiana; other included the 40 other
) tests of equality across southeastern exposure categories.
ge renal disease) tests for trend across southeastern exposure categories.
Table 3 Crude and adjusted prevalence odds ratios for albuminuria and reduced kidney function and hazard ratios for incident ESRD, by race and
southeastern residence duration categories
Model Lifetime southeastern exposure Pa
White Black
None <Half ≥Half All None <Half ≥Half All
Prevalence odds ratios (95% CI) for albuminuria
Unadjusted Ref. 0.86 (0.74-1.01) 0.99 (0.87-1.13) 1.08 (0.96-1.22) Ref. 0.92 (0.80-1.05) 0.77 (0.65-0.91) 1.02 (0.90-1.16) 0.054
Adjustedb
+ demographics Ref. 0.87 (0.75-1.02) 1.04 (0.91-1.18) 1.16 (1.02-1.31) Ref. 0.87 (0.76-1.00) 0.80 (0.68-0.95) 1.08 (0.95-1.22) <0.001
+ SES Ref. 0.89 (0.76-1.04) 1.02 (0.89-1.17) 1.08 (0.96-1.23) Ref. 0.84 (0.73-0.97) 0.78 (0.66-0.92) 0.99 (0.86-1.13) 0.178
+ clinical Ref. 0.86 (0.73-1.01) 0.94 (0.82-1.08) 1.00 (0.88-1.14) Ref. 0.86 (0.74-1.00) 0.74 (0.62-0.89) 0.92 (0.80-1.05) 0.265
Prevalence odds ratios (95% CI) for reduced kidney function
Unadjusted Ref. 0.82 (0.70-0.97) 0.92 (0.80-1.05) 1.03 (0.91-1.17) Ref. 1.07 (0.90-1.26) 0.82 (0.67-1.01) 1.05 (0.90-1.23) 0.051
Adjustedb
+ demographics Ref. 0.97 (0.81-1.15) 0.98 (0.80-1.22) 1.19 (1.03-1.40) Ref. 0.89 (0.75-1.05) 1.00 (0.87-1.16) 1.13 (0.99-1.30) 0.843
+ SES Ref. 0.94 (0.79-1.13) 0.96 (0.77-1.18) 1.11 (0.94-1.31) Ref. 0.91 (0.76-1.08) 0.99 (0.86-1.05) 1.08 (0.94-1.23) 0.937
+ clinical Ref. 0.96 (0.81-1.15) 0.92 (0.74-1.14) 1.06 (0.80-1.26) Ref. 0.88 (0.74-1.35) 0.93 (0.80-1.08) 1.00 (0.87-1.15) 0.878
Hazard ratios (95% CI) for incident end-stage renal disease
Unadjusted Ref. 0.51 (0.19-1.34) 0.91 (0.45-1.84) 0.53 (0.24-1.18) Ref. 1.16 (0.70-1.93) 1.11 (0.60-1.06) 1.73(1.10-2.74) 0.014
Adjustedb
+ demographics Ref. 0.52 (0.20-1.36) 0.94 (0.47-1.89) 0.55 (0.25-1.24) Ref. 1.16 (0.69-1.93) 1.11 (0.60-2.07) 1.74(1.10-2.75) 0.013
+ SES Ref. 0.54 (0.21-1.44) 0.93 (0.46-1.88) 0.51 (0.23-1.14) Ref. 1.17 (0.70-1.96) 1.09 (0.59-2.04) 1.66 (1.04-2.66) 0.013
+ clinical Ref. 0.51 (0.19-1.36) 0.91 (0.45-1.84) 0.50 (0.22-1.14) Ref. 1.23 (0.74-2.06) 1.02 (0.54-1.93) 1.63 (1.02-2.61) 0.011
Southeastern U.S. states included: North Carolina, South Carolina, Georgia, Alabama, Mississippi, Tennessee, Arkansas, and Louisiana; other included the 40 other contiguous U.S. states (excluding Alaska and Hawaii).
aP for interaction by Wald χ2 test between race and overall percentage of lifetime lived in the southeastern United States.


















Table 4 Adjusteda prevalence odds ratios for albuminuria and reduced kidney function and hazard ratios for incident ESRD, by income, race, and southeastern
residence duration




None <Half ≥Half All None <Half ≥Half All
Prevalence odds ratios (95% CI) for albuminuria
Income < $35,000 Ref. 0.97 (0.74-1.26) 0.99 (0.80-1.23) 1.01 (0.83-1.26) Ref. 0.85 (0.70-1.04) 0.75 (0.60-0.95) 0.94 (0.78-1.12) 0.415 0.538
Income ≥ $35,000 Ref. 0.86 (0.68-1.07) 0.89 (0.72-1.09) 1.02 (0.84-1.23) Ref. 0.86 (0.66-1.11) 0.71 (0.52-0.98) 0.98 (0.76-1.26) 0.859
Prevalence odds ratios (95% CI) for reduced kidney function
Income < $35,000 Ref. 0.86 (0.65-1.14) 0.94 (0.75-1.18) 1.06 (0.87-1.29) Ref. 0.97 (0.77-1.22) 1.00 (0.76-1.32) 1.02 (0.82-1.27) 0.838 0.053
Income ≥ $35,000 Ref. 0.79 (0.61-1.01) 0.89 (0.71-1.11) 0.82 (0.66-1.03) Ref. 0.99 (0.71-1.39) 0.59 (0.37-0.94) 1.17 (0.83-1.64) 0.034
Hazard ratios (95% CI) for incident end-stage renal disease
Income < $35,000 Ref. 0.50 (0.11-2.28) 1.16 (0.47-2.89) 0.43 (0.14-1.38) Ref. 1.57 (0.81-3.04) 1.51 (0.70-3.28) 1.98 (1.08-3.64) 0.069 0.028
Income ≥ $35,000 Ref. 0.66 (0.18-2.46) 0.56 (0.15-2.07) 0.79 (0.24-2.56) Ref. 0.82 (0.32-2.10) 0.20 (0.03-1.53) 0.56(0.17-1.82) 0.797
Southeastern U.S. states included: North Carolina, South Carolina, Georgia, Alabama, Mississippi, Tennessee, Arkansas, and Louisiana; other included the 40 other contiguous U.S. states (excluding Alaska and Hawaii).
aDemographics: age, gender, race (overall models only); SES: education, income clinical; diabetes, hypertension (by self-reported medications or glucose/BP).
bP for interaction by Wald χ2 test for race × southeastern residence duration, within income category.
cP for interaction by Wald χ2 test for income × race × southeastern residence duration. All lower-order interaction terms (income × race, income × duration, and race × duration) were also included in these models to
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tions of diabetes and hypertension—strong risk factors for
development and progression of CKD—with the U.S.
southeastern states and race, we expected that longer resi-
dence in this region would be associated with higher
prevalence of CKD and incidence of ESRD, and that the
associations might be even stronger in blacks compared to
whites.
However, in this national population-based cohort, while
we did observe increasing prevalence of diabetes and, to a
lesser extent, hypertension with higher duration of resi-
dence in the Southeast, the same was not true for the
prevalence of albuminuria and reduced kidney function,
or for incident ESRD. Differential CKD progression may
partially explain these results. Faster progression among
blacks is postulated to be responsible for decreased preva-
lence of CKD but increased ESRD incidence reported
among blacks as compared to whites [8]. Mortality also
differs by race: blacks with CKD have higher mortality at
every stage of CKD than comparable whites [9]. Thus, ra-
cial differences in CKD prevalence and CKD-related mor-
tality do not seem to account for the differences in
progression to ESRD [9,10]. However, higher early mortal-
ity and faster progression among blacks with CKD [11]
may mean that this study, which recruited community-
dwelling adults ≥45 years of age, was less likely to capture
blacks with earlier vs. advanced-stage CKD. Additionally,
if those with rapidly progressing CKD are more or less
sensitive to geographic risk factors than those with slowly
progressing CKD and were less likely to be captured in
our study, our results may be under- or over-estimating
the effect of southeastern residence duration on CKD, par-
ticularly among blacks.
Other important factors may partially account for our
observed results. For example, higher income could offset
deleterious effects of regional exposure in many ways,
including: increasing quality of medical care received; fa-
cilitating higher adherence to healthier lifestyles and pre-
scribed medical therapies; and improving residential
neighborhood, in terms of crime, education, or pollution.
Indeed, CKD has been shown to be more common in
those with lower income, particularly among blacks
[12-14]. Here, we found that the potential effect modifica-
tions by race for ESRD incidence were strongest in those
with lower income. Those with lower income may have
fewer opportunities to move for better educational and
job opportunities, which in turn may affect their risk for
incidence and progression of kidney disease.
Also, lifetime exposure (or cumulative life course ex-
posure) to the southeastern United States may not be as
important as other geographic factors, including early
regional exposure (or critical period exposure). In fact,
Howard et al. [5] reported that early stroke belt expos-
ure (place of birth, in childhood and/or adolescence)was more strongly associated with hypertension in
REGARDS, compared to other periods. The authors
found that early stroke belt exposure was a strong risk
factor, particularly among black participants; whereas
lifetime exposure was more strongly associated with
hypertension in white participants. Similarly, southeast-
ern U.S. place of birth and adult residence were both
shown to be independently associated with stroke mor-
tality, although childhood exposure was not available in
this study [15]. However, we found no association be-
tween southeastern residence during the first 18 years of
life and prevalence of albuminuria or reduced kidney
function. And, while protective and harmful effects were
suggested for ESRD among whites and blacks, respect-
ively, these results were neither statistically significant
nor substantially different (in either race) from those
obtained in our main analyses of lifetime exposure.
Residential mobility may also play a role. In general,
higher residential mobility is thought to be associated
with poorer health [16,17] and there is some evidence of
an association between higher mobility and higher
prevalence of hypertension [18]. However, it has been
suggested that such an effect is highly dependent on age
and health status at the time of migration [19]. Our re-
sults among blacks suggest that increased residential
mobility, at least in and out of the Southeast, may be
partially protective against albuminuria, although the re-
verse effect (declining health leading to decreased mobil-
ity) cannot be entirely ruled out since the duration of
albuminuria is unknown. Whether this can be explained
by the reasons for moving—e.g., educational or occupa-
tional opportunities—or by explanations such as the
“healthy migrant” effect or “salmon bias,” which are
often invoked to explain superior health status of immi-
grant populations [19,20], requires further research.
While these results demonstrate geographical variation
specifically within the United States, they are likely to be
relevant to international populations as well. For ex-
ample, in Japan, another highly industrialized country,
incidence rates of ESRD were shown to be higher in the
northern vs. southern regions, mirroring known regional
patterns of hypertension and stroke, despite a relatively
racially homogenous population compared to the United
States [21]. However, recent studies show that the geo-
graphic differences in ESRD incidence have all but
disappeared in the last decade in Japan [22], suggesting
that interventions may be effective in reducing geo-
graphic disparities. In India, the identification of such
existing geographic variations, as was seen with the na-
tional Indian CKD registry data, particularly with respect
to the prevalence of hypertensive CKD [23], is critical to
development and implementation of interventions that
could reduce or eliminate disparities, as has occurred in
Japan. Population genetic studies could help identify
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ancestry, who may be at higher risk [24]. Such popula-
tions could be targeted for early interventions that could
prevent the development of geographic disparities as
these populations transition to having chronic disease as
the main population health concern [25].
In addition to the limitations discussed above, there
are other limitations worthy of mention. First, residence
was self-reported and recall of all relocations to exact
year may be somewhat flawed. Also, this exposure re-
flects duration of residence in the Southeast but not ne-
cessarily the amount of exposure to cultural, lifestyle,
and/or environmental factors of the region, which may
account for increased risk of disease, including CKD.
Cohort effects could also an issue, although interactions
between age and duration of southeastern residence
were generally non-statistically significant, except in the
models of ESRD in whites. Both albuminuria and re-
duced kidney function are based upon single measure-
ments and some misclassification of CKD is likely.
Without good measures of diabetes and hypertension
control over time, we cannot ascertain whether these
differ geographically and what effect these might have
on CKD prevalence and ESRD incidence by region. Add-
itionally, unmeasured genetic and environmental factors
cannot be examined to determine the contributions of
each to observed differences. ESRD is rare, leading to
small numbers of events and possibly unstable estimates
in southeastern exposure categories, particularly for
income-stratified models. As with all observational stud-
ies, causal inference is limited. However, this study also
has several strengths, including a large study sample size
with adequate follow-up, ascertainment of ESRD
through active follow-up, and a sampling scheme that
provided adequate numbers of participants in both race
and Southeastern residence.
Conclusions
We found three unexpected findings in our analysis of
kidney disease and duration of residence in the South-
east. First, we found no association of southeastern resi-
dence duration with either albuminuria or reduced
kidney function, regardless of race. Second, lifetime
southeastern residence duration was associated with in-
creased risk of ESRD in blacks only, and we found no
evidence of a dose-response association with increasing
southeastern residence duration. Finally, blacks (but not
whites) with partial southeastern residence duration
were possibly less likely to have albuminuria than those
who lived their entire lives either within or outside of
the Southeast. Residential history data are not com-
monly collected in cohort studies. However, these un-
expected results regarding the effects of geography,
and particularly residence in the Southeast, on theprevalence and incidence of kidney disease among blacks
and whites may provide a motivation for the collection
and examination of more granular geographic data, in-
cluding both location and mobility, in prospective cohort
studies around the world.
Methods
Study design and population
The REGARDS study is a national population-based co-
hort study that recruited 30,239 community-dwelling par-
ticipants aged ≥45 years, of whom 55% were women, 42%
were black, and 58% were white. Enrollment of the cohort
occurred between 2003 and 2007. Approximately 56% of
the cohort was recruited from the southeastern states, and
the remaining 44% resided in the other 40 contiguous
states. Exclusion criteria were race/ethnicity other than
non-Hispanic African-American (black) or white, malig-
nancy or other medical conditions that prevented long-
term participation in the study, cognitive impairment,
nursing home residence, or non-English spoken language.
Consent was obtained verbally and later in writing. The
study was approved and monitored by institutional review
boards at all participating institutions.
Data collection
Detailed study methods have been published previously
[26]. Briefly, individuals were identified from commer-
cially available lists of residents, and recruited using an
initial mailing followed by telephone contact. Using a
computer-assisted telephone interview, trained inter-
viewers obtained demographic information and medical
history. A brief physical exam including blood pressure
measurements and collection of blood and urine sam-
ples was conducted in-person (usually in the home) 3-4
weeks after the telephone interview. A review of medica-
tion pill bottles was conducted as well. Self-administered
questionnaires were left with the participant to be com-
pleted after the in-person visit and returned by self-
addressed prepaid envelopes. Follow-up interviews are
attempted every 6 months, and there is a standard
protocol for tracking missed contacts.
Southeastern residence duration
Duration of residence in the southeastern United States
(North Carolina, South Carolina, Georgia, Alabama,
Mississippi, Tennessee, Arkansas, and Louisiana) was de-
termined at baseline by a self-administered study resi-
dential history questionnaire (“Places You Have Lived
Questionnaire”), on which participants report the loca-
tion (city/state) of all places where they had lived for at
least 1 year, from birth to study enrollment, and their
ages at each move. Southeastern residence duration was
defined as (time lived in the Southeast)/(time lived in
the United States)*100. Years lived out of the country, or
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n = 4725 participants, median of 5.5 years excluded).
Details of the process for matching reported cities with
U.S. Census data to minimize misspecification due to
misspellings or other mistakes have been published pre-
viously [5]. Briefly, participant reports of city/state were
matched with U.S. Census Bureau files; in the event of a
mismatch, the 10 mnemonically closest city/state combi-
nations were reviewed and evaluated as to the strength
of the match by study staff, and those participants with
addresses that lacked a strong match at the end of the
review process were removed. For analyses, southeastern
residence duration was categorized as none (0%), less
than half (>0 and <50%), half or more (≥50% and
<100%), and all (100%) of the participant’s life, to allow
for assessment of dose-response trends and to maintain
statistical power without subgroups.
Albuminuria
Urine albumin and creatinine were measured using a
BN ProSpec Nephelometer (Dade Behring, Marburg,
Germany; interassay coefficient of variation, 2.2-4.3%)
and Modular-P chemistry analyzer (Roche Hitachi,
Indianapolis, IN; interassay coefficient of variation,
2.6-8.6%), respectively [27]. Albuminuria was defined
as a baseline urinary albumin:creatine ratio (ACR) ≥
30 mg/g.
Reduced kidney function
Serum creatinine was measured by colorimetric reflect-
ance spectrophotometry using the Ortho Vitros Clinical
Chemistry System 950IRC instrument (Johnson &
Johnson Clinical Diagnostics, New Brunswick, NJ). eGFR
was calculated from isotope dilution mass spectrometry-
traceable serum creatinine values using the CKD-EPI
equation [28]. Reduced kidney function was defined as a
baseline estimated glomerular filtration rate (eGFR) <60
ml/min/1.73 m2, corresponding to stage 3-5 (moderate-
severe) CKD [29]. Sensitivity analyses using a stricter
cutoff of eGFR <45 ml/min/1.73 m2 (stages 3B-5), which
are more likely to be consistently reduced on multiple
measurement, were also conducted.
ESRD
The incidence of ESRD was determined by linked data
from the United States Renal Data System registry,
which records >90% of incident ESRD in the United
States. Follow-up time included time from study enroll-
ment to first ESRD treatment, death, or last date of
follow-up (9/1/09; mean follow-up, 3.4 years). Partici-
pants who initiated ESRD prior to enrollment were ex-
cluded from these analyses, and included participants
were censored at death or last date of follow-up.Potential confounders
Age, sex, race (white and black), income (<$20,000, $20-
34,999, $35,000-74,999, and > $75,000), education (less
than high school, high school graduate, some college,
college graduate), insurance (yes/no), doctor/clinic for
regular medical care (yes/no), self-reported use of oral
hypoglycemics/insulin or anti-hypertensive medications
(yes/no), current smoking (yes/no), immediate family
history of ESRD (yes/no), and use of drugs (yes/no)
known to affect CKD and its progression [non-steroidal
anti-inflammatory drugs, angiotensin-converting enzyme
inhibitors (ACEIs), and angiotensin receptor blockers
(ARBs)] were all collected at baseline. Height, weight,
and blood pressure were measured during the in-home
exam. Blood pressure (average of two measurements)
was measured per a standard protocol by a trained tech-
nician after the participant rested for 5 minutes, using
an appropriately sized cuff and an aneroid sphygmoman-
ometer (American Diagnostic Corporation, Hauppage,
NY). Glucose was measured by colorimetric reflectance
spectrophotometry using the Ortho Vitros Clinical
Chemistry System 950IRC instrument (Johnson &
Johnson Clinical Diagnostics, New Brunswick, NJ). Body
mass index (BMI) was calculated as weight (kg) divided
by height (m) squared. Diabetes was defined as self-
reported use of oral hypoglycemics or insulin, fasting
glucose ≥126 mg/dl, or random glucose ≥200 mg/dl.
Hypertension was defined as self-reported use of antihy-
pertensive medication, systolic blood pressure ≥140
mmHg or diastolic blood pressure ≥90 mmHg.
Statistical analyses
Participant characteristics were compared across cat-
egory of southeastern residence duration using χ2 or
ANOVA tests for categorical and continuous variables,
respectively. Crude prevalence of albuminuria and re-
duced kidney function and crude incidence of ESRD
were calculated by residence category and race. Race-
stratified logistic models were used to determine the
adjusted associations [prevalence odds ratios (PORs)]
between southeastern residence duration and the preva-
lence of albuminuria and reduced kidney function. Race-
stratified Cox proportional hazards models of time to
ESRD were used to obtain hazard ratios (HRs) of inci-
dent ESRD by race and southeastern residence duration.
Groups of covariates were entered sequentially to the
models to assess confounding: demographics (age, sex),
then socioeconomic status (SES; income, education), and
finally clinical (diabetes, hypertension). Sensitivity ana-
lyses were performed in which reduced kidney function
was defined by eGFR <45 ml/min/1.73 m2. Further sen-
sitivity analyses using evenly spaced (at 20% increments,
excluding 0% and 100%) cutoffs and using a dichotom-
ous variable assessing early-life southeastern residence
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also performed. Finally, potential effect modification by
income (with higher income potentially protecting indi-
viduals from any negative regional environmental effect)
was assessed via examination of the association within
low- and high-income groups (<$35,000 and > $35,000
annual income, respectively). Potential effect modifica-
tion by age, which might indicate a cohort effect,
wherein effects may be weaker in those born later (due
to society-level changes over time), was also assessed.
The statistical significance of interaction terms was
assessed with Wald χ2 tests. For this study, participants
were limited to those with lifetime residence information
(N = 27,070); of these participants, those with complete
information for assessment of prevalent albuminuria
(N = 25,797) and reduced kidney function (N = 25,965)
and free of ESRD at the start of the study (N = 26,950)
were included in respective analyses. All analyses were
performed using SAS v. 9.2 (SAS Institute, Cary, NC)
and Stata v. 12 (StataCorp, College Station, TX).
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